Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples